Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 60 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
A2 | 2 | 73 | F | Uterus | Endometrioid adenocarcinoma | * | T1CN0M0 | IC | Malignant |
A3 | 3 | 62 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1N0M0 | I | Malignant |
A4 | 4 | 49 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
A5 | 5 | 43 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1N0M0 | I | Malignant |
A6 | 6 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
A7 | 7 | 62 | F | Uterus | Endometrioid adenocarcinoma | 1 | 1BN0M0 | IB | Malignant |
A8 | 8 | 62 | F | Uterus | Endometrioid adenocarcinoma | * | T1CN1M0 | IIIC | Malignant |
A9 | 9 | 61 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1CN0M0 | IC | Malignant |
A10 | 10 | 63 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1CN0M0 | IC | Malignant |
B1 | 11 | 61 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
B2 | 12 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
B3 | 13 | 44 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
B4 | 14 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant |
B5 | 15 | 60 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1BN0M0 | IB | Malignant |
B6 | 16 | 58 | F | Uterus | Endometrioid adenocarcinoma | * | T1BN0M0 | IB | Malignant |
B7 | 17 | 70 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
B8 | 18 | 63 | F | Uterus | Endometrioid adenocarcinoma | 1 | T3AN0M0 | IIIA | Malignant |
B9 | 19 | 58 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
B10 | 20 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1BN0M0 | IB | Malignant |
C1 | 21 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1BN0M0 | IB | Malignant |
C2 | 22 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant |
C3 | 23 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1CN0M0 | IC | Malignant |
C4 | 24 | 63 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1CN0M0 | IC | Malignant |
C5 | 25 | 44 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1BN0M0 | IB | Malignant |
C6 | 26 | 55 | F | Uterus | Adenosquamous carcinoma | * | T1BN0M0 | IB | Malignant |
C7 | 27 | 54 | F | Uterus | Adenosquamous carcinoma | * | T2BN0M0 | IIB | Malignant |
C8 | 28 | 56 | F | Uterus | Adenosquamous carcinoma | * | T1BN0M0 | IB | Malignant |
C9 | 29 | 73 | F | Uterus | Adenosquamous carcinoma | * | T1BN0M0 | IB | Malignant |
C10 | 30 | 60 | F | Uterus | Squamous cell carcinoma | * | T2N0M0 | II | Malignant |
D1 | 31 | 39 | F | Abdominal cavity | Metastatic endometrioid adenocarcinoma | * | * | * | Metastasis |
D2 | 32 | 76 | F | Colon | Metastatic endometrioid adenocarcinoma | * | * | * | Metastasis |
D3 | 33 | 45 | F | Lymph node | Metastatic endometrioid adenocarcinoma of pelvic cavity | * | * | * | Metastasis |
D4 | 34 | 69 | F | Pelvic cavity | Metastatic endometrioid adenocarcinoma | * | * | * | Metastasis |
D5 | 35 | 51 | F | Ovary | Metastatic endometrioid adenocarcinoma | * | * | * | Metastasis |
D6 | 36 | 40 | F | Abdominal cavity | Metastatic endometrial adenosquamous carcinoma | * | * | * | Metastasis |
D7 | 37 | 37 | F | Uterus | Endometrial polyp | * | * | * | Hyperplasia |
D8 | 38 | 57 | F | Uterus | Endometrial polyp | * | * | * | Hyperplasia |
D9 | 39 | 69 | F | Uterus | Endometrial polyp | * | * | * | Hyperplasia |
D10 | 40 | 47 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E1 | 41 | 83 | F | Uterus | Severe atypical hyperplasia of endometrium | * | * | * | Hyperplasia |
E2 | 42 | 52 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E3 | 43 | 65 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E4 | 44 | 40 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E5 | 45 | 43 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E6 | 46 | 37 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E7 | 47 | 49 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E8 | 48 | 70 | F | Uterus | Moderate atypical hyperplasia of endometrium | * | * | * | Hyperplasia |
E9 | 49 | 51 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
E10 | 50 | 62 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
F1 | 51 | 52 | F | Uterus | Mild-moderate atypical hyperplasia of endometrium | * | * | * | Hyperplasia |
F2 | 52 | 69 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
F3 | 53 | 50 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
F4 | 54 | 64 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
F5 | 55 | 48 | F | Uterus | Endometrial simple hyperplasia | * | * | * | Hyperplasia |
F6 | 56 | 50 | F | Uterus | Endometrial adenomatous hyperplasia | * | * | * | Hyperplasia |
F7 | 57 | 69 | F | Uterus | Mild-moderate atypical hyperplasia of endometrium | * | * | * | Hyperplasia |
F8 | 58 | 44 | F | Uterus | Moderate atypical hyperplasia of endometrium | * | * | * | Hyperplasia |
F9 | 59 | 48 | F | Uterus | Mild-moderate atypical hyperplasia of endometrium | * | * | * | Hyperplasia |
F10 | 60 | 48 | F | Uterus | Chronic endometritis | * | * | * | Inflammation |
G1 | 61 | 60 | F | Uterus | Chronic endometritis | * | * | * | Inflammation |
G2 | 62 | 63 | F | Uterus | Chronic endometritis | * | * | * | Inflammation |
G3 | 63 | 65 | F | Uterus | Chronic endometritis | * | * | * | Inflammation |
G4 | 64 | 51 | F | Uterus | Chronic endometritis | * | * | * | Inflammation |
G5 | 65 | 41 | F | Uterus | Adjacent normal endometrium tissue (secretory) | * | * | * | NAT |
G6 | 66 | 41 | F | Uterus | Adjacent normal endometrium tissue (secretory) | * | * | * | NAT |
G7 | 67 | 37 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
G8 | 68 | 40 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
G9 | 69 | 53 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
G10 | 70 | 61 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
H1 | 71 | 41 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
H2 | 72 | 43 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
H3 | 73 | 44 | F | Uterus | Adjacent normal endometrium tissue (secretory) | * | * | * | NAT |
H4 | 74 | 34 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
H5 | 75 | 63 | F | Uterus | Adjacent normal endometrium tissue | * | * | * | NAT |
H6 | 76 | 42 | F | Uterus | Adjacent normal endometrium tissue (proliferative-phase) | * | * | * | NAT |
H7 | 77 | 45 | F | Uterus | Adjacent endometritis tissue | * | * | * | NAT |
H8 | 78 | 40 | F | Uterus | Normal endometrium tissue (proliferative-phase) | * | * | * | Normal |
H9 | 79 | 21 | F | Uterus | Normal endometrium tissue (proliferative-phase) | * | * | * | Normal |
H10 | 80 | 21 | F | Uterus | Normal endometrium tissue (secretory) | * | * | * | Normal |
I1 | 81 | | | | | | | | |